SEC Company Response from Q (QCLS) — Dec 3, 2019

Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: Dec. 3, 2019 · CIK: 0001321834 · Accession: 0001493152-19-018695

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-234447

Date

Dec. 3, 2019

Author

Christopher C. Schreiber

Form

CORRESP

Company

Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)

Letter

VIA EDGAR Division of Corporation Finance Re: Akers Biosciences, Inc. Registration Statement on Form S-1 Filed November 1, 2019, as amended File No. 333-234447

Dear Mr. Fischer:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 9:00 a.m. EST on Thursday, December 5, 2019, or as soon as thereafter practicable. The Company hereby represents to the U.S. Securities & Exchange Commission that the Company is not required to obtain stockholder approval to increase the number of authorized shares of common stock in order to consummate the public offering pursuant to the above mentioned Registration Statement.

Very
truly yours,
/s/
Christopher C. Schreiber

Show Raw Text

CORRESP
1
filename1.htm

Akers
Biosciences, Inc.

201
Grove Road

Thorofare,
NJ 08086

Telephone:
(856) 848-8698

December
3, 2019

VIA
EDGAR

Paul
Fischer

Division
of Corporation Finance

U.S.
Securities & Exchange Commission

100
F Street, NE

Washington,
D.C. 20549-4561

    Re:
    Akers Biosciences,
    Inc.

    Registration Statement
    on Form S-1

    Filed November 1,
    2019, as amended

    File No. 333-234447

Dear
Mr. Fischer:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Akers Biosciences, Inc. (the “Company”) hereby requests
acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 9:00 a.m. EST
on Thursday, December 5, 2019, or as soon as thereafter practicable. The Company hereby represents to the U.S. Securities &
Exchange Commission that the Company is not required to obtain stockholder approval to increase the number of authorized shares
of common stock in order to consummate the public offering pursuant to the above mentioned Registration Statement.

    Very
    truly yours,

    /s/
    Christopher C. Schreiber

    Christopher
    C. Schreiber

    Executive
    Chairman of the Board of Directors

    cc:
    Ellenoff
    Grossman & Schole LLP

    Haynes and Boone, LLP

SecProbe.io